2021
DOI: 10.1212/wnl.0000000000012033
|View full text |Cite|
|
Sign up to set email alerts
|

[ 11 C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease

Abstract: ObjectiveTo explore the possibilities of radioligands against the mitochondrial outer membrane protein TSPO as biomarkers for mitochondrial disease, we performed PET (PET)-MR brain imaging with [11C]PK11195 in 14 patients with genetically confirmed mitochondrial disease and 33 matched controls.MethodsA case-control study of PET-MR imaging with the TSPO radioligand [11C]PK11195.ResultsForty-six percent of symptomatic patients had volumes of abnormal radiotracer binding greater than the 95th percentile in contro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 52 publications
0
2
0
Order By: Relevance
“…Previous results have endorsed the potential of TSPO as an in vivo biomarker of mitochondrial pathology for PET imaging [30]. To further validate TSPO as a viable pharmacological target to reduce pathological neuroinflammatory conditions, we tested the effect of a recently developed, highly specific TSPO ligand, namely 18 F- GE-180 (S-N, N-diethyl-9-[2-18F-fluoroethyl]-5-methoxy 2,3,4,9-tetrahydro-1H- carbazole-4-carboxamide).…”
Section: Resultsmentioning
confidence: 99%
“…Previous results have endorsed the potential of TSPO as an in vivo biomarker of mitochondrial pathology for PET imaging [30]. To further validate TSPO as a viable pharmacological target to reduce pathological neuroinflammatory conditions, we tested the effect of a recently developed, highly specific TSPO ligand, namely 18 F- GE-180 (S-N, N-diethyl-9-[2-18F-fluoroethyl]-5-methoxy 2,3,4,9-tetrahydro-1H- carbazole-4-carboxamide).…”
Section: Resultsmentioning
confidence: 99%
“…In the article “[ 11 C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease” by van den Ameele et al, 1 panels E, H, K, and N of Figure 4 should be labeled “Patient < controls.” A corrected version of Figure 4 is available at links.lww.com/WNL/B478. The editorial staff regret the error.…”
mentioning
confidence: 99%